1. Home
  2. ABVX vs MBAV Comparison

ABVX vs MBAV Comparison

Compare ABVX & MBAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVX
  • MBAV
  • Stock Information
  • Founded
  • ABVX 2013
  • MBAV 2024
  • Country
  • ABVX France
  • MBAV United States
  • Employees
  • ABVX N/A
  • MBAV N/A
  • Industry
  • ABVX
  • MBAV
  • Sector
  • ABVX
  • MBAV
  • Exchange
  • ABVX Nasdaq
  • MBAV NYSE
  • Market Cap
  • ABVX 451.5M
  • MBAV 368.4M
  • IPO Year
  • ABVX N/A
  • MBAV 2024
  • Fundamental
  • Price
  • ABVX $6.71
  • MBAV $10.36
  • Analyst Decision
  • ABVX Strong Buy
  • MBAV
  • Analyst Count
  • ABVX 5
  • MBAV 0
  • Target Price
  • ABVX $33.80
  • MBAV N/A
  • AVG Volume (30 Days)
  • ABVX 96.0K
  • MBAV 125.5K
  • Earning Date
  • ABVX 03-24-2025
  • MBAV 01-01-0001
  • Dividend Yield
  • ABVX N/A
  • MBAV N/A
  • EPS Growth
  • ABVX N/A
  • MBAV N/A
  • EPS
  • ABVX N/A
  • MBAV 0.24
  • Revenue
  • ABVX $11,172,999.00
  • MBAV N/A
  • Revenue This Year
  • ABVX $284.20
  • MBAV N/A
  • Revenue Next Year
  • ABVX N/A
  • MBAV N/A
  • P/E Ratio
  • ABVX N/A
  • MBAV $43.63
  • Revenue Growth
  • ABVX 135.94
  • MBAV N/A
  • 52 Week Low
  • ABVX $4.77
  • MBAV $9.97
  • 52 Week High
  • ABVX $14.75
  • MBAV $10.91
  • Technical
  • Relative Strength Index (RSI)
  • ABVX 50.68
  • MBAV N/A
  • Support Level
  • ABVX $6.54
  • MBAV N/A
  • Resistance Level
  • ABVX $7.83
  • MBAV N/A
  • Average True Range (ATR)
  • ABVX 0.54
  • MBAV 0.00
  • MACD
  • ABVX -0.00
  • MBAV 0.00
  • Stochastic Oscillator
  • ABVX 30.00
  • MBAV 0.00

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

About MBAV M3-BRIGADE ACQUISITION V CORP

M3-Brigade Acquisition V Corp is a blank check company.

Share on Social Networks: